BixiaX.Xu (2006) Market differential evaluations of strategic alliances in the pharmaceutical/biotech industry, J. High Technol. Manage Res, 17(1), 43–52.
2.
NorallC.GerritsR. (2006) R&D cooperation, licensing and marketing in the biotechnology field: EC competition law aspects, World Competition Law Econom. Rev., 29(2), 229–245.
3.
RoijakkersNHagedoornJ. (2006) Inter-firm R&D partnering in pharmaceutical biotechnology since 1975: Trends, patterns, and networks, Res. Policy, 35(3), 431–446.
4.
HowardDCrokeC.MensahE.MullnerR. (2006) The performance of Medicare, Medicaid, and individual commercial products, J. Healthcare Manage., 51(3), 156–168.
5.
PrašnikarJŠkerljT. (2006) New product development process and time-to-market in the generic pharmaceutical industry, Ind. Market. Manage., 35(6), 690–702.
6.
SinghTSmithD. (2006) Direct-to-consumer prescription drug advertising: A study of consumer attitudes and behavioural intentions, J. Consumer Market., 22(7), 369–378.
